 |
|
|
|
|
|
 |
Learn about our Canadian operations.
|
|
|
|
|
|
|
|
|
|
|
|
 |
Explore opportunities in our entrepreneurial culture.
|
|
|
|
|
|
|
|
|
|
|
|
 |
Find out about what is new in our research and development.
|
|
|
|
|
|
|
|
|
|
|
|
 |
View a calendar of our events.
|
|
|
|
|
|
|
|
|
|
|
|
 |
See what's new for Genzyme in Canada.
|
|
|
|
|
|
|
|
Genzyme
Health Canada Endorsed Important Safety Information
Cerezyme® (imiglucerase for injection) Supply and Recommendations for Restarting Cerezyme. For Healthcare Professionals More> For Patients More>
For Preparation and Administration of Cerezyme® (imiglucerase for injection), Fabrazyme® (agalsidase beta), Myozyme® (alglucosidase alfa) and Aldurazyme® (laronidase) More>
For Preparation and Administration of Thyrogen® (thyrotropin alfa for injection) More>
|
Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right
Sanofi-aventis and Genzyme Corporation announced that they have entered into a definitive agreement under which sanofi-aventis is to acquire Genzyme for $74.00 per share in cash, or approximately $20.1 billion. More>
|
Introducing the New Genzyme Reimbursement Helpline
1-866-401-8323
A new reimbursement HELPLINE has been set up to help you get coverage for Renagel®, Thyrogen™ and Synvisc® under your insurance plan.
If you have questions about your coverage, you can call the new Reimbursement HELPLINE. Reimbursement specialists will be able to help you verify your benefits and answer any other questions you may have about reimbursement.
The Genzyme Reimbursement HELPLINE is open from 8:00 am until 8:00 pm EST Monday through Friday. Simply call 1-866-401-8323 and a specialist will be pleased to help you.
|
|
|
Genzyme Canada Inc. Home
Genzyme Corporate Home
